Harold Davis, MD
Gynecology · Scranton, PANPI 1427028950
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $20,177 of the $21,999 with a category attached, or 91.7%. Organon accounts for 65.3% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2019 at $6,742 and has fallen 97.8% since, to $150 in 2025. Among gynecology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 120 payments — averaging $183.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$14K
- Merck$7K
- AbbVie$245
- Pfizer$142
- Sumitomo Pharma America, Inc.$113
- Coloplast$69
- plus $541 from 17 others
What the payments were for
- Consulting fees$400%
- Speaking & faculty fees$20,17792%
- Travel & lodging$3362%
- Food & beverage$1,4136%
- Education$330%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 38 | $14,373 |
| Merck | 16 | $6,517 |
| AbbVie(2 entities) | 15 | $245 |
| Pfizer | 9 | $142 |
| Sumitomo Pharma America, Inc. | 7 | $113 |
| Coloplast | 2 | $69 |
| Astellas Pharma US Inc | 4 | $67 |
| Exeltis, USA Inc. | 4 | $66 |
| Myovant Sciences Inc. | 3 | $59 |
| Bayer | 2 | $57 |
| Mayne Pharma Commercial LLC | 4 | $47 |
| Hologic Sales And Service, LLC | 3 | $46 |
| Olympus America Inc. | 1 | $38 |
| Meditrina | 2 | $29 |
| Avion Pharmaceuticals | 2 | $27 |
| Smith+Nephew | 1 | $15 |
| Millicent US Inc | 1 | $15 |
| Exact Sciences | 1 | $15 |
| AMAG Pharmaceuticals, Inc. | 1 | $13 |
| Therapeuticsmd, Inc. | 1 | $13 |
| Amgen | 1 | $11 |
| Minerva Surgical, Inc | 1 | $11 |
| Lupin Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXPLANON$18,500
How this compares
$21,999 in reported general payments places this provider in the 90th percentile of 98 gynecology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 86 | $31,073 |
| GemtesaVibegron | 24 | $14,781 |
| MyrbetriqMirabegron | 20 | $13,790 |
| Estradiol | 204 | $9,755 |
| PremproEstrogen,con/M-Progest Acet | 12 | $5,365 |
| ImvexxyEstradiol | 11 | $4,004 |
| Clobetasol Propionate | 53 | $2,430 |
| Raloxifene Hcl | 25 | $1,915 |
| Estradiol (Twice Weekly)Estradiol | 19 | $1,758 |
| Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet | 12 | $1,472 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 61 | $1,003 |
| Alendronate Sodium | 60 | $767 |
| Estradiol (Once Weekly)Estradiol | 15 | $706 |
| Solifenacin Succinate | 19 | $552 |
| Medroxyprogesterone Acetate | 38 | $443 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin, Prempro | $142 | $36,43898 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $113 | $14,78124 claims |
| Astellas Pharma US IncMyrbetriq | $67 | $13,79020 claims |
| Therapeuticsmd, Inc.Imvexxy | $13 | $4,00411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 98 gynecology providers in Pennsylvania.
Other gynecology in Scranton
- Jordan KlebanoffNewtown Square$187K
- Harry ReichShavertown$136K
- Gretchen MakaiYork$102K
- Karen TangBryn Mawr$96K
- Joseph TalvacchiaPhiladelphia$85K
- David ToubWyncote$41K
- David EvansCarlisle$30K
- Reneita RossPhiladelphia$8K
- Marydonna RavasioButler$7K
- Vijay PalviaBethlehem$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.